| Category | BioTech |
| Employees | |
| Description | Influenza Research |
| Series A, 5/09 Polaris Venture Partners Flagship Ventures Lux Capital | $3.25M |
Parasol Therapeutics does research on influenza diagnostics and treatment. They were in seed/stealth stage as of June 2009.